Orthopedic medtech company Enovis entered into a binding offer to acquire eCential Robotics, expanding its surgical technology portfolio to include robotic automation.
The deal carries an upfront enterprise value of about $180 million, plus up to $41 million in contingent consideration tied to certain milestones, according to a Sept. 1 news release.
The transaction is expected to close by year-end 2026, subject to regulatory approvals. Enovis plans to fund the acquisition with cash on its balance sheet and availability under its existing revolving credit facility.
Enovis expects the deal to create a 100-basis-point headwind to its adjusted EBITDA margin in 2027. The company expects to return to year-over-year margin improvement in 2028.
The acquisition will add eCential Robotics’ robotic automation capabilities to Enovis’ ASTRA enabling technology platform. Enovis also plans to build a robotics center of excellence in France.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
